Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Caspase-3 Fluorometric Assay Kit: Precision in Apoptosis ...

    2025-12-04

    Caspase-3 Fluorometric Assay Kit: Precision in Apoptosis Assays

    Principle and Setup: Enabling Sensitive DEVD-Dependent Caspase Activity Detection

    The Caspase-3 Fluorometric Assay Kit (SKU: K2007) from APExBIO is engineered for robust, quantitative measurement of caspase-3 activity—a cornerstone of apoptosis research. Caspase-3, a key cysteine-dependent aspartate-directed protease, orchestrates apoptosis by cleaving downstream substrates and activating caspases 6 and 7. The kit leverages the fluorogenic substrate DEVD-AFC, which, upon cleavage by activated caspase-3, releases AFC, producing a yellow-green fluorescence (λmax = 505 nm) easily quantified using a fluorescence plate reader or fluorometer.

    This simple one-step assay is completed in 1–2 hours and includes cell lysis buffer, 2X reaction buffer, DTT, and the DEVD-AFC substrate. Its design ensures minimal hands-on time while providing high sensitivity for both endpoint and kinetic measurements of caspase-3 activity in cell lysates or purified enzyme systems. Optimal storage at -20°C preserves reagent stability, making it suitable for routine and high-throughput workflows in apoptosis assay and caspase signaling pathway investigations.

    Step-By-Step Workflow and Protocol Enhancements

    Standard Experimental Protocol

    1. Cell Harvesting and Lysis: Collect cells (treated or control) and resuspend in the supplied lysis buffer. Incubate on ice for 10–15 minutes, then centrifuge to clear lysates. Typical yield: 1–5 × 106 cells per sample.
    2. Reaction Setup: In a black 96-well plate, combine equal volumes of cleared lysate and 2X reaction buffer containing freshly added DTT. Add DEVD-AFC substrate (final: 50 μM) to each well.
    3. Fluorometric Measurement: Incubate at 37°C for 1–2 hours. Measure fluorescence (excitation: 400 nm, emission: 505 nm) at intervals for kinetics, or as a single endpoint.
    4. Data Analysis: Subtract background fluorescence (no lysate control). Normalize caspase-3 activity to total protein or cell number for quantitative comparison.

    Protocol Enhancements for Advanced Applications

    • Kinetic Monitoring: For real-time caspase activity measurement, collect fluorescence readings every 10–15 minutes. This enables detection of rapid caspase activation in early apoptosis.
    • Multiplexing with Apoptosis Markers: Combine the Caspase-3 Fluorometric Assay Kit with Annexin-V-FITC/PI staining or TUNEL assays for comprehensive cell apoptosis detection, as demonstrated in studies investigating cell death crosstalk (see advanced strategies).
    • High-Throughput Screening: The kit’s compatibility with 96-well and 384-well plates makes it ideal for drug screening or siRNA knockdown studies targeting the caspase signaling pathway in cancer and neurodegeneration models.

    Advanced Applications and Comparative Advantages

    Recent research has illuminated the central role of caspase-3 activity within complex cell death networks. For example, in a 2024 study (Zi et al., Int J Hyperthermia), hyperthermia and cisplatin co-treatment promoted caspase-8 accumulation and polyubiquitination, resulting in enhanced caspase-3 activation and synergistic induction of apoptosis and pyroptosis in cancer cells. The Caspase-3 Fluorometric Assay Kit enables direct measurement of this critical caspase-3 activation step, facilitating mechanistic dissection of upstream events and therapeutic interventions.

    Compared to colorimetric or less sensitive fluorometric kits, APExBIO’s assay provides:

    • High Sensitivity: Detects caspase-3 activity changes as low as 10–50% above background with minimal sample input.
    • Specificity: DEVD-AFC substrate ensures detection of DEVD-dependent caspase activity, minimizing off-target protease signal.
    • Speed and Convenience: One-step protocol, no wash steps, and rapid results support both routine and high-throughput needs.


    In the context of Alzheimer's disease research, this kit enables precise quantification of caspase-3 activation, a hallmark of neuronal apoptosis and neurodegeneration. Its performance is benchmarked in several resources, including:


    Troubleshooting and Optimization Tips

    • Low Signal or Sensitivity: Confirm the age and activity of the DEVD-AFC substrate; old or improperly stored substrate loses fluorescence yield. Always thaw and dilute reagents immediately before use.
    • High Background Fluorescence: Include no-lysate and no-substrate controls to subtract intrinsic fluorescence. Ensure plate wells are free of detergent or debris.
    • Sample Preparation: Use freshly harvested cells and rapid lysis. Protease inhibitors are not recommended in lysis buffer, as they may inhibit caspase-3.
    • Plate Selection: Black, flat-bottom plates minimize background and cross-talk. Avoid clear or white plates.
    • Reaction Timing: For maximal dynamic range, empirically determine optimal incubation time for your cell model; over-incubation can lead to substrate depletion and underestimated activity.

    For comprehensive troubleshooting, the Quantitative DEVD-Dependent Caspase Activity guide provides additional benchmarks for signal optimization and data normalization in apoptosis assay workflows.

    Future Outlook: Expanding Role in Apoptosis and Beyond

    As cell death research evolves, the Caspase-3 Fluorometric Assay Kit is poised to remain integral for dissecting programmed cell death modalities—apoptosis, pyroptosis, and necroptosis—across oncology, neurodegeneration, and immunology. Advances in combination therapies, such as the hyperthermia and cisplatin paradigm (Zi et al., 2024), highlight the need for precise, quantitative caspase activity measurement to unravel caspase signaling pathway crosstalk and therapeutic efficacy.

    Emerging applications include multiplexed detection with live-cell imaging, integration with high-throughput CRISPR screens, and usage in patient-derived organoid models. Continued enhancements in fluorometric sensitivity and workflow automation will further empower researchers to quantify cell apoptosis detection and track dynamic caspase regulation in complex systems.

    By offering reproducibility, speed, and specificity, the APExBIO Caspase-3 Fluorometric Assay Kit stands as a trusted partner for apoptosis research and caspase activity measurement, positioning your lab at the forefront of cell death discovery.